LAS VEGAS, Nov. 27, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV - News) is pleased to announce that Laurent Lecanu, Ph.D., Pharm.D., will present data for Samaritan’s promising Alzheimer’s drug Caprospinol (SP-233) at the Alzheimer’s Drug Development Summit in Arlington, VA on Friday, November 30th at 9:45a.m./ET. Dr. Lecanu will present Caprospinol as the first drug to demonstrate in animals that there is a correlation between clearing beta-amyloid from the brain and the recovery of memory function. Dr. Lecanu’s presentation is entitled ``Caprospinol Improves Brain Histopathology and Recovers Memory Function in a Rat Model of Alzheimer’s Disease.’'
